At 14 weeks of age, an average of 18% of the animals receiving TNFR1:IgG showed hyperglycemia (blood sugar >400 mg/dl) compared with 16% in the vector control group and by 24 weeks 73% in both vector treated groups had severe hyperglycemia (Figure 2A). Here, TNFRSF1A is linked to Hyperglycemia.